Literature DB >> 10699924

Malignant transformation and EGFR activation of immortalized mouse liver epithelial cells caused by HBV enhancer-X from a human hepatocellular carcinoma.

M Miyaki1, C Sato, K Sakai, M Konishi, K Tanaka, M Muraoka, R Kikuchi-Yanoshita, Y Nadaoka, H Kanda, T Kitagawa.   

Abstract

We have previously observed that all human hepatocellular carcinomas (HCCs) from HBV carriers examined had the integrated X region. In this study, HBV DNA was isolated from an integration site in one HCC that had a single, very small integrated viral DNA including the X region, but it had no expression of X gene as poly(A)RNA. It was found that HBV DNA was present between alphoid repetitive sequences, and it included Enhancer and X regions, encompassing the adr sequence from 910 to 1811. Nucleotides for 8 amino acids at the 3' end, a stop codon of X gene and a poly(A) signal downstream of X gene were lost by integration, and nucleotides for 7 amino acids and a stop codon were substituted by a connected alphoid sequence. When this cloned HBV DNA was transfected with an expression vector to an immortalized mouse liver epithelial cell line, MLE-10, malignant transformation occurred. Transformants having expressed poly(A)RNA of the X gene showed anchorage-independent growth in soft agar and tumor formation in the subcutis of nude mice. The mRNA level of EGFR was found to be remarkably enhanced in X-transformed cells, in contrast with the absence of this mRNA in parental and ras-transformed MLE-10. Our data provide evidence that the Enhancer-X region alone is the key contributor to the malignant change of pre-malignant liver cells in HBV carriers through activation of some specific genes, such as EGFR. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699924     DOI: 10.1002/(sici)1097-0215(20000215)85:4<518::aid-ijc12>3.0.co;2-7

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice.

Authors:  Dana R Crawford; Stephanie Ostrowski; Dilip Vakharia; Zoran Ilic; Stewart Sell
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 2.  Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Shilu Mathew; Hany Abdel-Hafiz; Abbas Raza; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-08

3.  Role of IGF-1 receptor in radiation response.

Authors:  Almudena Valenciano; Luis Alberto Henríquez-Hernández; Mercedes Moreno; Marta Lloret; Pedro Carlos Lara
Journal:  Transl Oncol       Date:  2012-02-01       Impact factor: 4.243

4.  Cytosolic phospholipase A(2)α protects against Fas- but not LPS-induced liver injury.

Authors:  Guiying Li; Weina Chen; Chang Han; Tong Wu
Journal:  J Hepatol       Date:  2011-04-14       Impact factor: 25.083

5.  Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cells.

Authors:  Bin-Wen Wu; Yuan Wu; Jia-Long Wang; Ju-Sheng Lin; Shu-Yu Yuan; Ai Li; Wu-Ren Cui
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

6.  Chromogenic in situ hybridization analysis of Epidermal Growth Factor Receptor gene/chromosome 7 numerical aberrations in hepatocellular carcinoma based on tissue microarrays.

Authors:  Evangelos Tsiambas; Loukas Manaios; Costas Papanikolopoulos; Dimitrios N Rigopoulos; Dimitrios Tsounis; Andreas Karameris; Aspasia Soultati; Antigoni Koliopoulou; Christos Kravvaritis; Theodoros Sergentanis; Efstratios Patsouris; Spyridon Dourakis
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

7.  ADAM17 mRNA expression and pathological features of hepatocellular carcinoma.

Authors:  Xiang Ding; Lian-Yue Yang; Gen-Wen Huang; Wei Wang; Wei-Qun Lu
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

8.  Cyclooxygenase-2 prevents fas-induced liver injury through up-regulation of epidermal growth factor receptor.

Authors:  Guiying Li; Chang Han; Lihong Xu; Kyu Lim; Kumiko Isse; Tong Wu
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

9.  Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences.

Authors:  Jennifer Ng; Jennifer Wu
Journal:  Hepat Mon       Date:  2012-10-25       Impact factor: 0.660

Review 10.  EGFR Signaling in Liver Diseases.

Authors:  Karin Komposch; Maria Sibilia
Journal:  Int J Mol Sci       Date:  2015-12-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.